Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab

Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab

Immune thrombocytopenic purpura (ITP) is one of the complications of systemic lupus erythematosus (SLE). Although corticosteroids are usually selected for initial therapy, some patients are corticosteroid-resistant and, therefore, require other immunosuppressants or splenectomy. However, the best tr...

Full description

Bibliographic Details
Main Authors: Kazuya Abe, Yuichi Ishikawa, Junichi Ishikawa, Michio Fujiwara, Yasuhiko Kita
Format: Article
Language:English
Published: Taylor & Francis Group 2019-10-01
Series:Immunological Medicine
Subjects:
systemic lupus erythematosus
rituximab
immune thrombocytopenic purpura
antigens
corticosteroids
Online Access:http://dx.doi.org/10.1080/25785826.2019.1696644

Similar Items

Similar Items